Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0002058369-25-000002
Filing Date
2025-07-28
Accepted
2025-07-28 13:24:16
Documents
1
Effectiveness Date
2025-07-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7446
  Complete submission text file 0002058369-25-000002.txt   8578
Mailing Address 4665 NAUTILUS CT S STE 300 BOULDER CO 80301
Business Address 4665 NAUTILUS CT S STE 300 BOULDER CO 80301 720-515-0395
Orbit Genomics, Inc. (Filer) CIK: 0002058369 (see all company filings)

EIN.: 813168686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-541191 | Film No.: 251154894